Correlation Between Davicom Semiconductor and Intech Biopharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Davicom Semiconductor and Intech Biopharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Davicom Semiconductor and Intech Biopharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Davicom Semiconductor and Intech Biopharm, you can compare the effects of market volatilities on Davicom Semiconductor and Intech Biopharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Davicom Semiconductor with a short position of Intech Biopharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Davicom Semiconductor and Intech Biopharm.

Diversification Opportunities for Davicom Semiconductor and Intech Biopharm

0.47
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Davicom and Intech is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Davicom Semiconductor and Intech Biopharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intech Biopharm and Davicom Semiconductor is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Davicom Semiconductor are associated (or correlated) with Intech Biopharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intech Biopharm has no effect on the direction of Davicom Semiconductor i.e., Davicom Semiconductor and Intech Biopharm go up and down completely randomly.

Pair Corralation between Davicom Semiconductor and Intech Biopharm

Assuming the 90 days trading horizon Davicom Semiconductor is expected to under-perform the Intech Biopharm. In addition to that, Davicom Semiconductor is 1.52 times more volatile than Intech Biopharm. It trades about -0.17 of its total potential returns per unit of risk. Intech Biopharm is currently generating about -0.17 per unit of volatility. If you would invest  2,930  in Intech Biopharm on September 3, 2024 and sell it today you would lose (220.00) from holding Intech Biopharm or give up 7.51% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Davicom Semiconductor  vs.  Intech Biopharm

 Performance 
       Timeline  
Davicom Semiconductor 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Davicom Semiconductor has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Intech Biopharm 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Intech Biopharm has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Davicom Semiconductor and Intech Biopharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Davicom Semiconductor and Intech Biopharm

The main advantage of trading using opposite Davicom Semiconductor and Intech Biopharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Davicom Semiconductor position performs unexpectedly, Intech Biopharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intech Biopharm will offset losses from the drop in Intech Biopharm's long position.
The idea behind Davicom Semiconductor and Intech Biopharm pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios